Fitchburg-based Arrhythmia Research Technology Inc., which produces sensors and technology for cardiac care, reported revenues of $6.3 million and a net loss of $375,000 for the first quarter of 2012. That's compared to $6.1 million in revenue and a net profit of $27,000 for the same period last year.
Net loss per share for the period, which ended March 31, was 13 cents, down from 1 cent during the same quarter in 2011. President and CEO
James E. Rouse said the loss was primarily a result of the company's continued investment in its startup medical services subsidiary WirelessDx.
Arrhythmia's Micron Products sensor business had strong sales, accounting for the slightly higher revenue over 2011, Rouse said.
|Today's Poll||Is your business considering changing its health plan so that it would offer employees less or require them to pay more?<